This was the first trial to prospectively evaluate the objective response rate in high-grade chemotherapy-naive MPNST using an identical chemotherapy regimen and stratification for NF1 and sporadic MPNST. Here, NF1 is linked to malignant peripheral nerve sheath tumor.